Home 2018-04-12T15:30:16+00:00
What we do—

Changing the world

UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.

Read More
Latest news—

UCLB spinout Orchard Therapeutics acquires rare disease gene therapy portfolio from GSK

The clinical-stage gene therapy company, announced its recent strategic agreement with GSK, to acquire its portfolio of approved and investigational rare disease gene therapies.

Read More
Featured Technology—

Novel method of analysis of stroke data

Stroke is the leading cause of adult disability in the UK at an estimated cost of £7 billion a year. UCL has developed a system for predicting clinical outcomes so as to provide advance information on the optimum clinical management of each patient.
Read more
Spotlight—

Children are not small adults.

When it comes to the use of medicines, children cannot be treated as small adults.  Find out how our spinout, Therakind, is ensuring that children’s medicine used today is both safe and effective.

Read More
Featured Technology—

SnakeGrid

SnakeGrid is a way of developing low-distortion coordinate systems for large engineering projects.

Read more

Latest news and highlights

Read More News

UCLB spinout Orchard Therapeutics acquires rare disease gene therapy portfolio from GSK

/ Spinout News
Today, the clinical-stage gene therapy company, announced its recent strategic agreement with GSK, to acquire its portfolio of approved and ...

Intrinsic Features in EE News Europe

/ UCLB News
Electronics industry publication, EE News Europe, features Intrinsic’s novel memristive RRAM devices, in a recent news article. The UCL spinout ...

UCL Technology Fund and UCL Business Feature in Sunday Times Article

Peter Evans of the Sunday Times has featured UCL Technology Fund and UCL Business (UCLB) in an article about the ...

Intrinsic launches new website

/ Spinout News, UCLB News
UCL spinout company, Intrinsic, launched its new website today. Intrinsic was established to commercialise the novel memristive RRAM devices developed ...

FIND THE RIGHT MATCH

Whether you’re an academic or looking for technologies, find your UCLB contact here.

 

Bringing innovation to life

0
Active spinouts
0
Active licences in 2016
0
Drug discoveries
0
New patent applications